Pricing Log in Create free account

Connect Biopharma Holdings Limited Sponsored ADR (CNTB) vs iBio, Inc. (IBIO)

Connect Biopharma Holdings Limited Sponsored ADR and iBio, Inc. are both Biotechnology companies. Connect Biopharma Holdings Limited Sponsored ADR and iBio, Inc. are of similar size ($46.1M and $44.4M). iBio, Inc. has the higher net margin (0.00% vs −2,298.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, iBio, Inc. leads on 12 and Connect Biopharma Holdings Limited Sponsored ADR on 2.

Valuation

Metric CNTB IBIO Biotechnology median
P/E n/m n/m 10.60
P/S 15.30 115.62 9.40
P/B 1.71 0.91 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.25 0.66
EV/Sales 4.87 (12.78) 9.02
Earnings yield (163.01%) (45.33%) (32.88%)
Free cash flow yield (132.91%) (31.04%) (23.13%)

Profitability

Metric CNTB IBIO Biotechnology median
Gross margin 100.00% 100.00% 68.51%
Operating margin (2,346.35%) 0.00% 0.00%
Net margin (2,298.93%) 0.00% 0.00%
Free cash flow margin (2,018.76%) 0.00% 0.00%
Return on equity (140.51%) (65.70%) (51.96%)
Return on assets (109.34%) (54.04%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CNTB IBIO Biotechnology median
Revenue growth (TTM) — (66.55%) 6.76%
EPS growth (last fiscal year) (257.14%) 81.71% 29.88%
Revenue growth, 5-year CAGR — (42.83%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CNTB IBIO Biotechnology median
Debt to equity 0.01 0.00 0.00
Current ratio 2.37 7.85 4.97
Net debt to EBITDA 0.77 2.57 1.01

Dividend

Metric CNTB IBIO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CNTB IBIO Biotechnology median
Market cap 46.08m 44.43m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack